Trial NCT00365937

View at ClinicalTrials.gov 
Org. Study IDs: LUC 05-003

Last trial update was posted on 2019-03-06

MeSH Interventions

Adjuvants, Immunologic Monatide (IMS 3015)

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

New regulatories of the peptides by the pharmaceutical company (the seller)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID